GRAFT-VERSUS-HOST DISEASE
Clinical trials for GRAFT-VERSUS-HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new GRAFT-VERSUS-HOST DISEASE trials appear
Sign up with your email to follow new studies for GRAFT-VERSUS-HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo for Graft-Versus-Host disease fails to enroll
Disease control TerminatedThis study tested a mix of drugs (cyclophosphamide, sirolimus, low-dose IL-2, and azacitidine) to treat severe graft-versus-host disease that didn't respond to steroids. Only 3 patients were enrolled before the trial was stopped early. The goal was to see if the treatment could c…
Matched conditions: GRAFT-VERSUS-HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Light therapy study sheds light on immune changes in transplant complication
Knowledge-focused TerminatedThis study looked at how extracorporeal photopheresis (ECP) — a treatment that uses light to modify a patient's own blood cells — affects the immune system in people with chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. Only 8 people were en…
Matched conditions: GRAFT-VERSUS-HOST DISEASE
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC